Publication | Open Access
Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
252
Citations
29
References
2007
Year
Single-agent doxorubicin remains the treatment of choice for patients with advanced soft tissue sarcoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1